Tyra Biosciences.
company in Carlsbad, United States
- Reports this week
- 0
- Active events
- 0
- Connections
- 24
What's happening
One to three months ago
-
Tyra Biosciences listed its shares on the stock exchange on August 6, 2026.Well supported6 reports1 development inside
-
Tyra Biosciences received positive analyst ratings and saw increased investment stakes from Geode Capital Management and BofA.Some support2 reports
-
Tyra Biosciences and Apogee Therapeutics are being compared based on their financial metrics.Some support1 report
-
On August 1, 2026, several firms made moves regarding Tyra Biosciences, including Mirae Asset increasing its position, Caitong buying, and Janus Henderson reducing its stake.Some support1 report
Gone quiet
No new reports in 90+ days-
Tyra Biosciences announced on June 30, 2025, that its study will enroll participants primarily in the US, with the announcement originating from Carlsbad.Speculative1 report
-
Tyra Biosciences presented its results at the ENDO 2025 conference.Speculative1 report
-
Tyra Biosciences is based in Carlsbad, California.Some support1 report
-
Todd Harris has been appointed CEO of Tyra Biosciences.Some support4 reports
No events began in the chosen period. Widen it, or reset.
Around Tyra Biosciences this week
News at the entities that move Tyra Biosciences most-
Manufacturers Life Insurance Company TransactionalManufacturers Life Insurance Company purchased a new position in NXP Semiconductors stock.Moves Tyra Biosciences
-
Geode Capital Management TransactionalPAVmed is facing the requirement of regulatory clearance for its company products, while also attracting institutional investment interest.Moves Tyra Biosciences
-
Nasdaq StructuralVMware's stock performance was tracked on the Nasdaq exchange on October 25, 2026.Moves Tyra Biosciences
-
Bank of America Mentioned togetherThe Office of the Comptroller of the Currency and U.S. Treasury fined Bank of America for reporting and compliance failures.Moves Tyra Biosciences
-
Jefferies Financial Group Mentioned togetherJefferies Financial Group initiated coverage on Moody's shares, and Morgan Stanley subsequently raised its price target for the company.Moves Tyra Biosciences
-
Securities and Exchange Commission StructuralBlackRock filed disclosures with the SEC regarding the iShares 0-3 Month Treasury Bond ETF.Moves Tyra Biosciences
Connections
The 10 strongest of 24, analyzed from the reporting. The bars show how strongly a change on one side reaches the other.-
Todd Harris Structural
Todd Harris serves as the CEO of Tyra Biosciences.
-
Nasdaq Structural
Tyra Biosciences is formally listed on the Nasdaq stock exchange.
-
Geode Capital Management Transactional
Geode Capital Management increased its investment stake in Tyra Biosciences.
-
Securities and Exchange Commission Structural
Tyra Biosciences is engaged in formal regulatory compliance by filing documentation with the Securities and Exchange Commission.
-
Manufacturers Life Insurance Company Transactional
Manufacturers Life Insurance Company purchased a new position in shares of Tyra Biosciences.
-
MarketBeat Mentioned together
MarketBeat lists Tyra Biosciences as a growth stock, placing it within a thematic group of high-growth companies.
-
Jefferies Financial Group Mentioned together
Jefferies provided market coverage by reaffirming a buy rating and price target for Tyra Biosciences.
-
Bank of America Mentioned together
Bank of America provided investment coverage for Tyra Biosciences, raising its price objective and issuing a 'buy' rating.
Show all 10 connections
-
Raymond James Financial Mentioned together
Raymond James Financial provided a strong-buy rating and price target for Tyra Biosciences.
-
Carlsbad Shared context
Tyra Biosciences is located and conducts trials in Carlsbad, California.
History
Events by the month they beganAugust 2026
4 events- Tyra Biosciences listed its shares on the stock exchange on August 6, 2026.
- Tyra Biosciences received positive analyst ratings and saw increased investment stakes from Geode Capital Management and BofA.
- Tyra Biosciences and Apogee Therapeutics are being compared based on their financial metrics.
- On August 1, 2026, several firms made moves regarding Tyra Biosciences, including Mirae Asset increasing its position, Caitong buying, and Janus Henderson reducing its stake.
June 2026
4 events- Tyra Biosciences announced on June 30, 2025, that its study will enroll participants primarily in the US, with the announcement originating from Carlsbad.
- Tyra Biosciences presented its results at the ENDO 2025 conference.
- Tyra Biosciences is based in Carlsbad, California.
- Todd Harris has been appointed CEO of Tyra Biosciences.